Niagen Bioscience Announces $10 Million Share Repurchase Program to Boost Investor Confidence

Niagen Bioscience has announced a $10 million share repurchase program to buy back outstanding common stock over approximately 24 months. The program will be executed through open market purchases, privately negotiated transactions, or other methods, subject to applicable laws and market conditions. There is no obligation to repurchase any shares, and the program may be modified, suspended, or terminated at any time.